Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 8,707.50%24.1K | -153,883.33%-27.72K | 17.87%-5.47K | 99.32%-3.3K | 113.11%3.66K | 99.29%-280 | 99.91%-18 | 98.34%-6.66K | 77.66%-488.47K | 93.63%-27.9K |
| Net income from continuing operations | 83.06%-24.28K | 99.12%-476 | 50.05%-33.54K | 79.41%-325.38K | 93.60%-60.75K | 31.44%-143.34K | 71.52%-54.15K | 70.97%-67.15K | 25.81%-1.58M | -65.42%-949.58K |
| Operating gains losses | -74.48%1.66K | -587.37%-29.12K | 99.26%-70 | -96.01%5.71K | -91.02%12.91K | 380.83%6.5K | -353.11%-4.24K | -8,202.63%-9.47K | 843.87%143.02K | 141.65%143.77K |
| Depreciation and amortization | --0 | --0 | --0 | -37.42%2.01K | -93.45%53 | -17.57%657 | -58.83%653 | 4,193.33%644 | 46.10%3.21K | 700.99%809 |
| Securities amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | -251.36%-21.35K | ---21.35K | --0 | --0 | --0 | --14.11K | --0 |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --284.13K | ---- |
| Other non cashItems | 2.30%1.51K | -54.28%1.56K | 13.79%1.59K | -77.12%7.79K | 14.21%1.5K | -85.00%1.48K | -71.23%3.41K | -87.32%1.4K | 70.20%34.05K | -88.54%1.32K |
| Change In working capital | -66.37%45.21K | -99.40%324 | -60.90%26.55K | -46.51%327.93K | -85.50%71.3K | -16.67%134.42K | -63.50%54.3K | 136.00%67.91K | 751.52%613.11K | 655.54%491.65K |
| -Change in receivables | --0 | --0 | --0 | -38.49%35.51K | -92.55%15.25K | --0 | --0 | 109.16%20.26K | 186.95%57.72K | 287.17%204.79K |
| -Change in prepaid assets | 92.72%-261 | 45.68%-641 | -1.48%-206 | -121.56%-6.63K | 58.92%-1.66K | -281.99%-3.59K | -103.13%-1.18K | 95.82%-203 | -5.33%30.76K | -108.53%-4.04K |
| -Change in payables and accrued expense | -67.05%45.47K | -98.26%965 | -44.09%26.76K | -43.00%299.06K | -80.16%57.71K | 7.74%138.01K | -18.80%55.48K | 28.25%47.85K | 971.35%524.63K | 925.89%290.9K |
| Cash from discontinued investing activities | 0 | |||||||||
| Operating cash flow | 8,707.50%24.1K | -153,883.33%-27.72K | 17.87%-5.47K | 99.32%-3.3K | 113.11%3.66K | 99.29%-280 | 99.91%-18 | 98.34%-6.66K | 77.88%-488.47K | 93.93%-27.9K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | -145.16%-14.11K | 0 | |||
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---14.11K | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---14.11K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -145.16%-14.11K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | -54.16%52.99K | 3,520.70%46.59K | 0 | 0 | -74.90%6.4K | -95.07%115.59K | -100.16%-1.36K |
| Net issuance payments of debt | --0 | --0 | --0 | -54.16%52.99K | 3,520.70%46.59K | --0 | --0 | -74.90%6.4K | -71.74%115.59K | -101.57%-1.36K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | -54.16%52.99K | 3,520.70%46.59K | --0 | --0 | -74.90%6.4K | -95.07%115.59K | -100.16%-1.36K |
| Net cash flow | ||||||||||
| Beginning cash position | -49.18%155 | -18.25%327 | 568.54%5.23K | -99.80%782 | -99.24%226 | -91.85%305 | -89.35%400 | -99.80%782 | 72.30%387.23K | 411.58%29.56K |
| Current changes in cash | 8,707.50%24.1K | -153,883.33%-27.72K | -2,019.38%-5.47K | 112.84%49.69K | 271.70%50.25K | -101.09%-280 | -38.46%-18 | 99.93%-258 | -332.50%-386.99K | -107.76%-29.27K |
| Effect of exchange rate changes | -12,085.57%-24.09K | 35,872.73%27.55K | 557.26%567 | -8,510.04%-45.25K | -9,371.72%-45.25K | 209.23%201 | ---77 | -726.67%-124 | 113.61%538 | -88.64%488 |
| End cash Position | -26.99%165 | -49.18%155 | -18.25%327 | 568.54%5.23K | 568.54%5.23K | -99.24%226 | -91.85%305 | -89.35%400 | -99.80%782 | -99.80%782 |
| Free cash from | 8,707.50%24.1K | -153,883.33%-27.72K | 17.87%-5.47K | 99.32%-3.3K | 113.11%3.66K | 99.29%-280 | 99.91%-18 | 98.34%-6.66K | 77.88%-488.47K | 93.93%-27.9K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.